Osteoarthritis Clinical Trial
Official title:
Evaluation of a New Formulation Useful for the Osteoarthrosis Treatment
Abstract
Kondrium, is a pharmaceutical composition for the treatment of osteoarthritis (OA). This
study was designed to evaluate the efficacy and safety of kondrium in the treatment of OA of
knee.
A 3 month, randomized, double-blind, active-controlled, parallel-group study will be carried
out. 117 patients with OA of the knee will be randomized to receive 1 intra-articular
monthly injection of 5 mL of one of the following: 75 mg/mL of Kondrium, 82.5 mg/mL of
Kondriumf or 8 mg/mL of methylprednisolone once a month during 3 months. The primary
efficacy variable will be the change from baseline to final assessment in the Western
Ontario and McMaster University OA index (WOMAC subscale score for pain), and Lequesne´s
functional index.
The WOMAC osteoarthritis index is a validated, multidimensional, disease specific, health
status measure. It probes clinically important patient relevant symptoms in the areas of
pain, stiffness and physical function in patients with hip and/or knee osteoarthritis. It
consists of 24 questions in three separated subscales (5 questions on pain subscale, 17
questions on physical function subscales and 2 questions on stiffness subscale), each scored
in analog scale from 0 to 10 points (0 representing no pain, 10 representing extreme pain).
Each subscale score was weighed 10 points, thus 30 was the maximum punctuation for WOMAC
total score.
The Lequesne index is a 10-question interview-style survey given to patients with
osteoarthritis of the knee. It has 5 questions pertaining to pain or discomfort, 1 question
dealing with maximum distance walked, and 4 questions about daily activities. The total
questionnaire is scored on a 0 to 24 scale, with lower scores meaning less functional
impairment.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04657926 -
A Trial of APPA in the Treatment of Knee Osteoarthritis
|
Phase 2 | |
Completed |
NCT02536833 -
A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects
|
Phase 2 | |
Completed |
NCT03014037 -
Comparing Mesenchymal Stem Cell Counts in Unilateral vs. Bilateral Posterior Superior Iliac Spine Bone Marrow Aspiration
|
N/A | |
Recruiting |
NCT05937542 -
A Qualitative Investigation of CLEAT Participants
|
||
Completed |
NCT03644615 -
A Mindfulness Program (MBSR) in the Management of Symptomatic Hip and Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT06061367 -
Muscles Strength and Gait Parameteres After TKA
|
||
Withdrawn |
NCT04976972 -
A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation
|
N/A | |
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT03850665 -
Comparison of Functional Outcome in Patients After Hip Arthroplasty Depending on Surgical Approach
|
N/A | |
Completed |
NCT02826902 -
Effect of Anesthesia on Quality of Recovery in Patients Undergoing Correctional Tibial Osteotomy - A Randomized Controlled Trial
|
N/A | |
Completed |
NCT04402502 -
Dynamic 4DCT to Examine Wrist Carpal Mechanics
|
N/A | |
Completed |
NCT02923700 -
Leukocyte-rich PRP vs Leukocyte-poor PRP for the Treatment of Knee Cartilage Degeneration: a Randomized Controlled Trial
|
Phase 4 | |
Completed |
NCT04564053 -
Study of Safety, Tolerability and Pharmacokinetics of LNA043 in Japanese Osteoarthritis Participants
|
Phase 1 | |
Completed |
NCT05070871 -
A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women
|
N/A | |
Not yet recruiting |
NCT05036174 -
Diphenhydramine Ointment for Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT02666443 -
Low Dose Dexamethasone in Supraclavicular Blocks
|
N/A | |
Recruiting |
NCT02912429 -
Onlay vs. Inlay Patellofemoral Arthroplasty
|
N/A | |
Active, not recruiting |
NCT02723929 -
Effects of tDCS and tUS on Pain Perception in OA of the Knee
|
||
Terminated |
NCT02820766 -
Journey II BCS CMS Total Knee System Compared to Other PS Total Knee Systems in PT Setting
|
N/A | |
Withdrawn |
NCT02921594 -
Kinematic Comparison of Vanguard XP and Vanguard CR Total Knee Arthroplasties
|
N/A |